project id: TCGA-STAD; case submitter id: TCGA-D7-A4YU; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.94; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.71; rna integrity number: 8.9; age at index: 73; days to birth: -26781; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1939; age at diagnosis: 26781; ajcc pathologic m: M0; ajcc pathologic n: N3a; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 500.0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8211/3; primary diagnosis: Tubular adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 125; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-D7-A4YU-01A-21; percent lymphocyte infiltration: 25.0; percent monocyte infiltration: 2.0; percent necrosis: 3.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 57.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0;